Friday, March 24, 2023
EVERSANA® announced a partnership with ChemoMouthpiece, LLC to support the launch and commercialisation of its medical device, the Chemo Mouthpiece™, to assist oncology patients across the United States.
Under the terms of the partnership, EVERSANA will provide a full range of commercialisation services to support the launch of the Chemo Mouthpiece™ in the U.S. including but not limited to market access strategy, compliance and regulatory services, patient services, field deployment solutions, data and analytics, pricing strategy and 3PL distribution services.
The Chemo Mouthpiece™ is an intraoral ice pack that delivers cryotherapy to the oral cavity of a patient receiving chemotherapy. It proactively manages and treats oral mucositis, a common and painful side effect of chemotherapy. The Chemo Mouthpiece™ efficiently cools the entire oral cavity. Patients can freeze the device at home and take it with them to be used during treatment, creating a simple solution for an unmet patient need.
